Abbreviations: HGF, hepatocyte growth factor; HGFR, HGF receptor; siRNA, small interfering RNA; HUVECs, human umbilical vein endothelial cells; FBS, fetal bovine serum; EBM-2, endothelial basal medium-2; DMSO, dimethyl sulfoxide. In the present study, we show for the first time that Src activity is required for the HGF-induced capillary morphogenesis of endothelial cells. Cambrex, Walkersville, MD, and the cells were cultured in endothelial cell basal medium-2 (EBM-2) supplemented with 2% FBS, 10 ng/ml VEGF-A, 20 ng/ml fibroblast growth factor-2, 10 ng/ml endothelial growth factor, 10 ng/ml insulin-like growth factor-I, 50 g/ml ascorbic acid, 100 ng/ml heparin, and 10 pM dexamethasone.
Hepatocyte growth factor (HGF) induces angiogenesis. HGF stimulates the proliferation, secretion of proteases, migration, survival, and differentiation (capillary morphogenesis or tube formation) of endothelial cells through its specific receptor tyrosine kinase, c-Met/hepatocyte growth factor receptor (HGFR) [1] [2] [3] [4] [5] . In addition, HGF mobilizes endothelial progenitor cells from bone marrow, which contributes to vasculogenesis [6] . HGF also indirectly induces angiogenesis through the upregulation of platelet-activating factor, vascular endothelial growth factor, interleukin 8, and ets-1, and downregulation of thrombospondin 1 [7] [8] [9] [10] [11] . The Ras/mitogen-activated protein kinase pathway and phosphoinositide 3-kinase/Akt pathway are implicated in cell survival, matrix metalloproteinase production, proliferation, and cell migration [4, [12] [13] [14] .
However, signal transduction pathways leading to the differentiation of HGF-treated endothelial cells are largely unknown.
The Src family protein tyrosine kinases play crucial roles in a variety of cellular responses, embryonic development, and pathological conditions such as tumor progression and angiogenesis [15, 16] . Blockade of common signaling molecules downstream of a panel of growth factor receptors such as the Src family of kinases is an attractive strategy to inhibit tumor angiogenesis because the angiogenic signals via several proangiogenic growth factor receptors could be inhibited simultaneously. Since signals via HGFR are involved in tumor progression and angiogenesis in many human cancers, it is important to determine whether the Src family kinases are required for HGF-induced angiogenesis. While a Src family kinase inhibitor PP1 inhibited HGF-mediated nitric oxide production along with proliferation of human umbilical vein endothelial cells (HUVECs) [17] , the role of Src family kinases in HGF-induced cellular responses of endothelial cells is still poorly understood.
In the present study, we show for the first time that Src activity is required for the HGF-induced capillary morphogenesis of endothelial cells. Cambrex, Walkersville, MD, and the cells were cultured in endothelial cell basal medium-2 (EBM-2) supplemented with 2% FBS, 10 ng/ml VEGF-A, 20 ng/ml fibroblast growth factor-2, 10 ng/ml endothelial growth factor, 10 ng/ml insulin-like growth factor-I, 50 g/ml ascorbic acid, 100 ng/ml heparin, and 10 pM dexamethasone.
Materials and methods

Materials
Capillary morphogenesis assay MSS31 cells suspended in serum-free -MEM with or without indicated treatments were cultured between two layers of type I collagen gels for 18-20 h, as described previously [19] . Briefly, MSS31 cells were seeded onto the first collagen gel layer in the presence or absence of the indicated treatments. After 4 h the medium was removed, and the cells were overlaid with a second collagen gel layer, and the culture was continued for 16 h. HUVECs suspended in EBM-2 medium containing 0.5% FBS with or without the indicated treatments were seeded onto growth factor-reduced Matrigel and cultured for up to 24 h [20] . To quantify the length of capillaries, 3 different phase-contrast photomicrographs (x 4 objectives) per well were taken, and the length of each capillary was measured using NIH image software (version 1.64). The capillary length of HGF-stimulated parental or empty vector-transfected cells was set to 1.0. In vitro kinase assay The in vitro kinase assay for Src was described previously [21] .
Transfection of kinase-inactive Src into MSS31 cells
Briefly, cells were serum-starved for 2 h then were either left untreated or stimulated with HGF for 10 min. The Src was immunoprecipitated, and the kinase assay was performed using acid-denatured enolase as the substrate. The incorporation of [-
32 P] ATP into enolase was examined by SDS-PAGE, followed by autoradiography.
Immunoblotting Ten percent of the total cell lysate for the in vitro kinase assay or the cell lysate from 4,000 siRNA-treated cells was separated on SDS-polyacrylamide gels.
Proteins were electrotransferred onto polyvinylidene difluoride membranes. Membranes were incubated with the indicated antibodies followed by incubation with peroxidase-conjugated secondary antibodies. Proteins were visualized using enhanced chemiluminescence reagents (Pierce Biotechnology, Rockford, IL) and exposed to X-ray film.
Statistical analysis Values are presented as the mean capillary length ± SD. Differences between two groups were determined by Mann-Whitney's U test. Differences were considered significant when the P value was less than 0.05.
Results
HGF induces capillary morphogenesis in MSS31 cells and is dependent on Src activity
We examined the effect of HGF on capillary morphogenesis in MSS31 cells. As shown in Fig. 1 
Src activity is required for HGF-induced capillary morphogenesis in HUVECs
We next examined the effect of HGF on capillary morphogenesis in HUVECs. As shown in Fig. 3A , HGF induced capillary morphogenesis in HUVECs and this effect was 
Discussion
In the present study, we show that HGF activated Src in two different endothelial cells, MSS31 cells and HUVECs. A Src family kinase inhibitor, PP2 inhibited HGF-induced capillary morphogenesis in these cells ( Fig. 1 and 3A) . Src was involved in the fibroblast growth factor-2 (FGF-2) induced migration of endothelial cells [22] . The Src family inhibitor PP2 inhibited FGF-2-induced capillary morphogenesis, tube formation, and in vivo angiogenesis [21, 23, 24] . Expression of dominant negative Fyn blocked FGF-2 and angiopoietin 2 (Ang2) induced tube formation [21, 25] . Inhibition of Src attenuated VEGF-induced in vivo angiogenesis by inducing apoptosis of endothelial cells [26] . Src is also involved in VEGF-induced migration [27, 28] . Selective downregulation of Src family kinases by small interfering RNA (siRNA) demonstrated that Yes was important for VEGF-mediated migration, whereas Fyn was required for VEGF-promoted tube formation [29] . It has been shown that the anti-VEGF-A monoclonal antibody bevacizumab (Avastin) showed antivascular effect in human rectal cancer [30] . However, targeting solely VEGF signaling failed to demonstrate potent antitumor activity in clinical trials. Recent study using a preclinical model has shown that blocking VEGF signaling changed the VEGF-dependent angiogenesis to other proangiogenic factor-dependent angiogenesis, such as FGF-2 [31] .
Thus, the inhibition of signaling molecules commonly working downstream of several proangiogenic growth factor receptors, such as Src family kinases, by small molecule protein kinase inhibitors could represent a broad range antiangiogenic strategy.
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